This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Muriel I. Kaiser-Kupfer, MD; Gary L. Peck, MD; Rafael C. Caruso, MD; Myles J. Jaffe, MD; John J. DiGiovanna, MD; Earl G. Gross, MD

Arch Ophthalmol. 1986;104(1):69-70.

Abstract
• Five patients with basal cell carcinoma received fenretinide. Two patients while receiving the drug had evidence of abnormal rod photoreceptor function that reversed rapidly on cessation of therapy. We speculate that fenretinide may interfere with the binding of vitamin A to opsin or with the transport of vitamin A.

Author Affiliations
From the Clinical Branch, National Eye Institute (Drs Kaiser-Kupfer, Caruso, and Jaffe), the Dermatology Branch, National Cancer Institute (Drs Peck and DiGiovanna), and the Cancer Prevention Studies Branch, Division of Cancer Prevention and Control, National Cancer Institute (Dr Gross), National Institutes of Health, Bethesda, Md.

Footnotes
Accepted for publication Oct 7, 1985.

Reprint requests to Clinical Branch, National Eye Institute, National Institutes of Health, Bldg 10, Room 10 N226, Bethesda, MD 20892 (Dr Kaiser-Kupfer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does use of isotretinoin rule out a career in flying?
Mollan et al.
Br J Ophthalmol 2006;90:957-959.
ABSTRACT | FULL TEXT  

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)
Villablanca et al.
JCO 2006;24:3423-3430.
ABSTRACT | FULL TEXT  

Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study
Puduvalli et al.
JCO 2004;22:4282-4289.
ABSTRACT | FULL TEXT  

Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients: Toxicity, Pharmacokinetic, and Biomarker Evaluations
Lawrence et al.
JCO 2001;19:2754-2763.
ABSTRACT | FULL TEXT  

Retinoid Metabolism in the Prostate: Effects of Administration of the Synthetic Retinoid N-(4-Hydroxyphenyl)retinamide
Lewis and Hochadel
Cancer Res. 1999;59:5947-5955.
ABSTRACT | FULL TEXT  

Effects of Fenretinide (4-HPR) on Dark Adaptation
Caruso et al.
Arch Ophthalmol 1998;116:759-763.
ABSTRACT | FULL TEXT  

Osteoporosis Is a Toxic Effect of Long-term Etretinate Therapy
DiGiovanna et al.
Arch Dermatol 1995;131:1263-1267.
ABSTRACT  

Adverse Reaction to Fenretinide, A Synthetic Retinoid
Gross et al.
Arch Dermatol 1991;127:1849-1850.
ABSTRACT  

Side Effects and Long-term Toxicity of Synthetic Retinoids
Yob and Pochi
Arch Dermatol 1987;123:1375-1378.
ABSTRACT  

Abnormal Retinal Function Associated With Isotretinoin Therapy for Acne
Weleber et al.
Arch Ophthalmol 1986;104:831-837.
ABSTRACT